Stock Research for NVAX

Current Price


Latest Update: 2018-03-19 10:41:00

$ 2.0800
$ 2.0700
$ 2.0750

Featured Broker: TradeStation

Get the due diligence for another stock.


NVAX Stock Chart & Research Data

The NVAX chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the NVAX chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


NVAX Due diligence Resources & Stock Charts

The NVAX stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View NVAX Detailed Price Forecast - CNN Money CNN View NVAX Detailed Summary - Google Finance
Yahoo View NVAX Detailed Summary - Yahoo! Finance Zacks View NVAX Stock Research & Analysis -

Stock Analysis

TradeIdeas View NVAX Trends & Analysis - Trade-Ideas Barrons View NVAX Major Holders - Barrons
NASDAQ View NVAX Call Transcripts - NASDAQ Seeking View NVAX Breaking News & Analysis - Seeking Alpha
Spotlight View NVAX Annual Report - OTC Report View NVAX OTC Short Report -
TradeKing View NVAX Fundamentals - TradeKing Charts View NVAX SEC Filings - Bar Chart
WSJ View Historical Prices for NVAX - The WSJ Morningstar View Performance/Total Return for NVAX - Morningstar
MarketWatch View the Analyst Estimates for NVAX - MarketWatch CNBC View the Earnings History for NVAX - CNBC
StockMarketWatch View the NVAX Earnings - StockMarketWatch MacroAxis View NVAX Buy or Sell Recommendations - MacroAxis
Bullish View the NVAX Bullish Patterns - American Bulls Short Pains View NVAX Short Pain Metrics -

Social Media Mentions

StockTwits View NVAX Stock Mentions - StockTwits PennyStocks View NVAX Stock Mentions - PennyStockTweets
Twitter View NVAX Stock Mentions - Twitter Invest Hub View NVAX Investment Forum News - Investor Hub
Yahoo View NVAX Stock Mentions - Yahoo! Message Board Seeking Alpha View NVAX Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for NVAX - Insider Cow View Insider Transactions for NVAX - Insider Cow
CNBC View NVAX Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for NVAX - OTC Markets
Yahoo View Insider Transactions for NVAX - Yahoo! Finance NASDAQ View Institutional Holdings for NVAX - NASDAQ

Stock Charts

FinViz View NVAX Stock Insight & Charts - StockCharts View NVAX Investment Charts -
BarChart View NVAX Stock Overview & Charts - BarChart Trading View View NVAX User Generated Charts - Trading View

Latest Financial News for NVAX

Why Novavax's CEO called last quarter 'the most significant' in corporate history
Posted on Friday March 16, 2018

"These are results that advance both programs in their respective clinical trials and create momentum for our execution during the remainder of 2018 and beyond," Erck said in a conference call with analysts after the company released its fourth quarter and year-end financial results Wednesday evening. "There's no other product anywhere near us, and we're looking forward to having the first RSV vaccine," Erk said.

Edited Transcript of NVAX earnings conference call or presentation 14-Mar-18 9:00pm GMT
Posted on Thursday March 15, 2018

Q4 2017 Novavax Inc Earnings Call

Today’s Research Reports on Trending Tickers: Novavax and RXi Pharmaceuticals
Posted on Thursday March 15, 2018

NEW YORK, NY / ACCESSWIRE / March 15, 2018 / U.S. markets' slide extended on Wednesday as concerns over a potential trade war with China continues to grow. The Dow Jones Industrial Average dropped 1.00 ...

Novavax reports 4Q loss
Posted on Wednesday March 14, 2018

On a per-share basis, the Gaithersburg, Maryland-based company said it had a loss of 16 cents. The results missed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment ...

Warning: DOMDocument::load(): StartTag: invalid element name in, line: 1 in /home/allsites/ on line 494

Warning: DOMDocument::load(): Extra content at the end of the document in, line: 1 in /home/allsites/ on line 494

Enter a stock symbol to view the stock details.